Record Number of Abstracts Accepted for the 9th World Congress on Gastrointestinal Cancer(R)

More than 400 abstracts have been accepted for presentation at the
9th World Congress on Gastrointestinal Cancer(R) in Barcelona, Spain
from 27-30 June 2007, representing the latest research from across the
globe in colon, esophageal, gastric, liver, pancreatic and rectal
cancer. The Congress, presented by Imedex Medical Education, in
partnership with the European Society for Medical Oncology (ESMO), is
the premier platform for specialists in cancer research, leading
oncologists and practicing clinicians to review the state-of-the-art
in gastrointestinal cancer and share the latest information on its
multidisciplinary management. 3,500 healthcare providers from 100
different countries are expected to attend.

The internationally recognized faculty will include Aaron
Ciechanover, MD, DSc, laureate of the 2004 Nobel Prize in Chemistry.
55 additional experts will participate in the scientific program,
chaired by Mario Dicato, MD of the Luxembourg Medical Center in
Luxembourg and Eric Van Cutsem, MD, PhD of the University Hospital
Gasthuisberg in Leuven, Belgium.

The scientific agenda is enhanced this year by expanded meet the
expert sessions, providing attendees the extended opportunity to
interact with leading specialists. The Congress will also introduce a
new nurses program, featuring topics of special interest to oncology
nurses, and an expert consensus report on rectal cancer. Continuing
the successful initiative begun in 2006, a Saturday morning session
will focus on young medical oncologists, providing information
relevant to new practitioners in the field, and a dedicated surgery
session will provide the latest information for surgical oncologists.

About Imedex Medical Education

Based in Alpharetta, Georgia, USA, Imedex Medical Education.
(www.imedex.com) is an industry leader in providing accredited medical
education services. With more than 22 years experience in medical
education, Imedex Medical Education concentrates on developing
proprietary independent CME programs worldwide and collaborates with
medical associations and health care companies to produce a full range
of medical education products. With innovative and focused scientific
programs, Imedex continually exceeds the expectations of thousands of
physicians, researchers, nurses and pharmaceutical representatives
each year.

Imedex Medical Education has extensive relationships with leading
healthcare professionals and opinion leaders in many fields of
medicine. Imedex provides a fully staffed medical resource department
as well as in-house business development, project management,
marketing and graphic and web-design services. Founded in 1985 in The
Netherlands, Imedex established its US-based operations in 1987.

About the European Society for Medical Oncology (ESMO)

The European Society for Medical Oncology (ESMO) is the leading
European non-profit, professional organization for medical oncology
with a focus on promoting multidisciplinary cancer treatment around
the world.

ESMO unites medical oncologists, oncology specialists, healthcare
professionals, caregivers, patients and policy makers in a global
alliance committed to eradicating cancer and ensuring equal access to
high quality treatment for all patients. Through state-of-the-art
education and training programs, ESMO plays an instrumental role in
providing the oncology community with the most up-to-date scientific
research and information available. ESMO publishes articles on all
aspects of clinical oncology through its flagship journal, Annals of
Oncology. ESMO is dedicated to educating and supporting oncologists,
optimizing patient care, disseminating cancer-specific information to
the public, and advocating patient rights. As an authoritative voice
in the fight against cancer, ESMO provides both the platform and the
consultative expertise to influence national and international
organizations as well as European authorities, in order to establish
common standards for a multidisciplinary approach to cancer treatment.
More information about ESMO and its activities can be found at
www.esmo.org